Trials / Unknown
UnknownNCT06154187
Study to Evaluate the Efficacy and Safety of PBK_L2201 in Postmenopausal Women With Osteoporosis
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel, Phase III Study to Evaluate the Efficacy and Safety of PBK_L2201 in Postmenopausal Women With Osteoporosis
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Pharmbio Korea Co., Ltd. · Industry
- Sex
- Female
- Age
- 50 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial was multicenter, randomized, double-blind, placebo-controlled, parallel, phase III bridge study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PBK_L2201 | Abaloparatide-SC 80 μg was to be self-administered daily using a Pen Injector device. |
| DRUG | Placebo | Placebo was formulated similar to abaloparatide-SC. |
Timeline
- Start date
- 2024-02-01
- Primary completion
- 2025-05-01
- Completion
- 2025-11-01
- First posted
- 2023-12-04
- Last updated
- 2023-12-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06154187. Inclusion in this directory is not an endorsement.